Changing the course of autoimmune disease

Inspired by patients. Driven to make an impact.

Aurinia’s Response to COVID-19

View

Latest News

January 8, 2021 • 12:00am EST

Aurinia Pharmaceuticals to Present at Two Upcoming Virtual Healthcare Conferences

Read Press Release View All News

December 17, 2020 • 12:00am EST

Aurinia Announces Collaboration and Licensing Agreement with Otsuka Pharmaceutical Co., Ltd. for the Development and Commercialization of Voclosporin in Europe and Japan

Read Press Release View All News

December 15, 2020 • 12:00am EST

Aurinia and Lonza Announce Exclusive Agreement for Dedicated Voclosporin Manufacturing Capacity

Read Press Release View All News